Show simple item record

Maintenance of GLUT4 expression in smooth muscle prevents hypertension‐induced changes in vascular reactivity

dc.contributor.authorAtkins, Kevin B.en_US
dc.contributor.authorSeki, Yoshinorien_US
dc.contributor.authorSaha, Jharnaen_US
dc.contributor.authorEichinger, Felixen_US
dc.contributor.authorCharron, Maureen J.en_US
dc.contributor.authorBrosius, Frank C.en_US
dc.date.accessioned2015-03-05T18:24:43Z
dc.date.available2016-04-01T15:21:07Zen
dc.date.issued2015-02en_US
dc.identifier.citationAtkins, Kevin B.; Seki, Yoshinori; Saha, Jharna; Eichinger, Felix; Charron, Maureen J.; Brosius, Frank C. (2015). "Maintenance of GLUT4 expression in smooth muscle prevents hypertension‐induced changes in vascular reactivity." Physiological Reports (2): n/a-n/a.en_US
dc.identifier.issn2051-817Xen_US
dc.identifier.issn2051-817Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/110755
dc.description.abstractPrevious studies have shown that expression of GLUT4 is decreased in arterial smooth muscle of hypertensive rats and mice and that total body overexpression of GLUT4 in mice prevents enhanced arterial reactivity in hypertension. To demonstrate that the effect of GLUT4 overexpression on vascular responses is dependent on vascular smooth muscle GLUT4 rather than on some systemic effect we developed and tested smooth‐muscle‐specific GLUT4 transgenic mice (SMG4). When made hypertensive with angiotensin II, both wild‐type and SMG4 mice exhibited similarly increased systolic blood pressure. Responsiveness to phenylephrine, serotonin, and prostaglandin F2α was significantly increased in endothelium‐intact aortic rings from hypertensive wild‐type mice but not in aortae of SMG4 mice. Inhibition of Rho‐kinase equally reduced serotonin‐stimulated contractility in aortae of hypertensive wild‐type and SMG4‐mice. In addition, acetylcholine‐stimulated relaxation was significantly decreased in aortic rings of hypertensive wild‐type mice, but not in rings of SMG4 mice. Inhibition of either prostacylin receptors or cyclooxygenase‐2 reduced relaxation in rings of hypertensive SMG4 mice. Inhibition of cyclooxygenase‐2 had no effect on relaxation in rings of hypertensive wild‐type mice. Cyclooxygenase‐2 protein expression was decreased in hypertensive wild‐type aortae but not in hypertensive SMG4 aortae compared to nonhypertensive controls. Our results demonstrate that smooth muscle expression of GLUT4 exerts a major effect on smooth muscle contractile responses and endothelium‐dependent vasorelaxation and that normal expression of GLUT4 in vascular smooth muscle is required for appropriate smooth muscle and endothelial responses.e12299In the smooth muscle of aortae of hypertensive mice, expression of GLUT4 is decreased. Maintenance of aortic smooth muscle GLUT4 expression prevents hypertension‐mediated changes in vasomotor response. These effects include decreasing/preventing endothelial dysfunction.en_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherContractilityen_US
dc.subject.otherCOX‐2en_US
dc.subject.otherendothelial‐dysfunctionen_US
dc.subject.otherGLUT4en_US
dc.subject.otherIP‐receptorsen_US
dc.subject.otherrelaxationen_US
dc.titleMaintenance of GLUT4 expression in smooth muscle prevents hypertension‐induced changes in vascular reactivityen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPhysiologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/110755/1/phy212299.pdf
dc.identifier.doi10.14814/phy2.12299en_US
dc.identifier.sourcePhysiological Reportsen_US
dc.identifier.citedreferenceMarcus, R. G., R. England, K. Nguyen, M. J. Charron, J. P. Briggs, and F. C. 3rd Brosius. 1994. Altered renal expression of the insulin‐responsive glucose transporter GLUT4 in experimental diabetes mellitus. Am. J. Physiol. 267: F816 – F824.en_US
dc.identifier.citedreferenceBanz, W. J., M. A. Abel, and M. B. Zemel. 1996. Insulin regulation of vascular smooth muscle glucose transport in insulin‐sensitive and resistant rats. Horm. Metab. Res. 28: 271 – 275.en_US
dc.identifier.citedreferenceBergandi, L., F. Silvagno, I. Russo, C. Riganti, G. Anfossi, E. Aldieri, et al. 2003. Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 23: 2215 – 2221.en_US
dc.identifier.citedreferenceBrosius, F. C. 3rd, J. P. Briggs, R. G. Marcus, M. Barac‐Nieto, and M. J. Charron. 1992. Insulin‐responsive glucose transporter expression in renal microvessels and glomeruli. Kidney Int. 42: 1086 – 1092.en_US
dc.identifier.citedreferenceBryant, N. J., R. Govers, and D. E. James. 2002. Regulated transport of the glucose transporter GLUT4. Nat. Rev. Mol. Cell Biol. 3: 267 – 277.en_US
dc.identifier.citedreferenceCannon, C. P., and P. J. Cannon. 2012. COX‐2 inhibitors and cardiovascular risk. Science 336: 1386 – 1387.en_US
dc.identifier.citedreferenceFeng, M., S. Whitesall, Y. Zhang, M. Beibel, L. D'Alecy, and K. DiPetrillo. 2008. Validation of volume‐pressure recording tail‐cuff blood pressure measurements. Am. J. Hypertens. 21: 1288 – 1291.en_US
dc.identifier.citedreferenceGrassie, M. E., L. D. Moffat, M. P. Walsh, and J. A. MacDonald. 2011. The myosin phosphatase targeting protein (MYPT) family: a regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1 δ. Arch. Biochem. Biophys. 510: 147 – 159.en_US
dc.identifier.citedreferenceHilgers, R. H., J. Jr Todd, and R. C. Webb. 2007. Increased PDZ‐RhoGEF/RhoA/Rho kinase signaling in small mesenteric arteries of angiotensin II‐induced hypertensive rats. J. Hypertens. 25: 1687 – 1697.en_US
dc.identifier.citedreferenceHirano, K., D. N. Derkach, M. Hirano, J. Nishimura, and H. Kanaide. 2003. Protein kinase network in the regulation of phosphorylation and dephosphorylation of smooth muscle myosin light chain. Mol. Cell. Biochem. 248: 105 – 114.en_US
dc.identifier.citedreferenceHirano, K., M. Hirano, and H. Kanaide. 2004. Regulation of myosin phosphorylation and myofilament Ca2+ sensitivity in vascular smooth muscle. J. Smooth Muscle Res. 40: 219 – 236.en_US
dc.identifier.citedreferenceIto, M., T. Nakano, F. Erdodi, and D. J. Hartshorne. 2004. Myosin phosphatase: structure, regulation and function. Mol. Cell. Biochem. 259: 197 – 209.en_US
dc.identifier.citedreferenceKatz, E. B., A. E. Stenbit, K. Hatton, R. DePinho, and M. J. Charron. 1995. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 377: 151 – 155.en_US
dc.identifier.citedreferenceLima, V. V., F. R. Giachini, H. Choi, F. S. Carneiro, Z. N. Carneiro, Z. B. Fortes, et al. 2009. Impaired vasodilator activity in deoxycorticosterone acetate‐salt hypertension is associated with increased protein O‐GlcNAcylation. Hypertension 53: 166 – 174.en_US
dc.identifier.citedreferenceLund‐Johansen, P. 1983. Haemodynamics in early essential hypertension–still an area of controversy. J. Hypertens. 1: 209 – 213.en_US
dc.identifier.citedreferenceMarchesi, C., A. Rehman, Y. Rautureau, D. A. Kasal, M. Briet, A. Leibowitz, et al. 2013. Protective role of vascular smooth muscle cell PPAR? in angiotensin II‐induced vascular disease. Cardiovasc. Res. 97: 562 – 570.en_US
dc.identifier.citedreferenceMulvany, M. J. 2005. Abnormalities of the resistance vasculature in hypertension: correction by vasodilator therapy. Pharmacol. Rep. 57 ( Suppl. ): 144 – 150.en_US
dc.identifier.citedreferencePark, J. L., R. D. Loberg, D. Duquaine, H. Zhang, B. K. Deo, N. Ardanaz, et al. 2005. GLUT4 facilitative glucose transporter specifically and differentially contributes to agonist‐induced vascular reactivity in mouse aorta. Arterioscler. Thromb. Vasc. Biol. 25: 1596 – 1602.en_US
dc.identifier.citedreferenceSeko, T., M. Ito, Y. Kureishi, R. Okamoto, N. Moriki, K. Onishi, et al. 2003. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ. Res. 92: 411 – 418.en_US
dc.identifier.citedreferenceTsao, T. S., R. Burcelin, E. B. Katz, L. Huang, and M. J. Charron. 1996. Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes 45: 28 – 36.en_US
dc.identifier.citedreferenceVirdis, A., A. Bacca, R. Colucci, E. Duranti, M. Fornai, G. Materazzi, et al. 2013. Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase‐2 in oxidative stress generation. Hypertension 62: 337 – 344.en_US
dc.identifier.citedreferenceWang, J., W. Niu, Y. Nikiforov, S. Naito, S. Chernausek, D. Witte, et al. 1997. Targeted overexpression of IGF‐I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. J. Clin. Invest. 100: 1425 – 1439.en_US
dc.identifier.citedreferenceWeber, D. S., and R. C. Webb. 2001. Enhanced relaxation to the rho‐kinase inhibitor Y‐27632 in mesenteric arteries from mineralocorticoid hypertensive rats. Pharmacology 63: 129 – 133.en_US
dc.identifier.citedreferenceWong, M. S., and P. M. Vanhoutte. 2010. COX‐mediated endothelium‐dependent contractions: from the past to recent discoveries. Acta Pharmacol. Sin. 31: 1095 – 1102.en_US
dc.identifier.citedreferenceWong, W. T., X. Y. Tian, and Y. Huang. 2013. Endothelial dysfunction in diabetes and hypertension: cross talk in RAS, BMP4, and ROS‐dependent COX‐2‐derived prostanoids. J. Cardiovasc. Pharmacol. 61: 204 – 214.en_US
dc.identifier.citedreferenceYu, Y., E. Ricciotti, R. Scalia, S. Y. Tang, G. Grant, Z. Yu, et al. 2012. FitzGerald. Vascular COX‐2 modulates blood pressure and thrombosis in mice. Sci. Transl. Med. 4: 132ra54.en_US
dc.identifier.citedreferenceArmoni, M., C. Harel, M. Ramdas, and E. Karnieli. 2014. CYP2E1 Impairs GLUT4 gene expression and function: NRF2 as a possible mediator. Horm. Metab. Res. 46: 477 – 483.en_US
dc.identifier.citedreferenceAtkins, K. B., D. Johns, S. Watts, R. Clinton Webb, and F. C. Brosius 3rd. 2001. Decreased vascular glucose transporter expression and glucose uptake in DOCA‐salt hypertension. J. Hypertens. 19: 1581 – 1587.en_US
dc.identifier.citedreferenceAtkins, K. B., C. A. Northcott, S. W. Watts, and F. C. Brosius. 2005. Effects of PPAR‐gamma ligands on vascular smooth muscle marker expression in hypertensive and normal arteries. Am. J. Physiol. Heart Circ. Physiol. 288: H235 – H243.en_US
dc.identifier.citedreferenceAtkins, K. B., A. Prezkop, J. L. Park, J. Saha, D. Duquaine, M. J. Charron, et al. 2007. Preserved expression of GLUT4 prevents enhanced agonist‐induced vascular reactivity and MYPT1 phosphorylation in hypertensive mouse aorta. Am. J. Physiol. Heart Circ. Physiol. 293: H402 – H408.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.